• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

ImmuONE: Venture Capital Funding History

ImmuONE

To add a bio or update company history, please click update information.

News from ImmuONE

    ImmuONE raises £600k follow-on from investors to expand 3D lung model as an alternative to animal testingImmuONE raises £600k follow-on from investors to expand 3D lung model as an alternative to animal testing
    ImmuONE
    13 Mar 2025

    ImmuONE raises £600k follow-on from investors to expand 3D lung model as an alternative to animal testing

    ImmuONE provides a 3D human lung laboratory model that replaces animal testing, allowing companies to assess respiratory safety, inflammation and long-term effects of chemicals, drugs and consumer products more reliably.

ImmuONE
  • Life Sciences
  • Milton Keynes, United Kingdom
  • £600k
  • immuone.com
  • Update Information

More venture news

  • Oyster Therapeutics secures a £45m Series A round from CE-Ventures to develop an oral drug for neurodegenerative diseases
    Oyster Therapeutics
    13 Nov 2026

    Oyster Therapeutics secures a £45m Series A round from CE-Ventures to develop an oral drug for neurodegenerative diseases

    Series ALife Sciences
  • Neobe lands a £5m seed round led by ARC Ventures to deliver cancer drugs directly into solid tumours
    Neobe Therapeutics
    10 Nov 2026

    Neobe lands a £5m seed round led by ARC Ventures to deliver cancer drugs directly into solid tumours

    SeedLife Sciences
  • PhaSER Biomedical secures a £2m grant from Gates Foundation to discover new treatments for neglected diseases
    PhaSER Biomedical
    9 Nov 2026

    PhaSER Biomedical secures a £2m grant from Gates Foundation to discover new treatments for neglected diseases

    GrantLife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn